Press Release
NeuroVasc Enrolls First Patient in U.S. IDE Clinical Trial
NeuroVasc Technologies, Inc. announced that the first patient has been treated in its U.S. IDE Clinical Trial, ENVI RCT – NeuroVasc Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke.